Lv41
718 积分 2023-02-15 加入
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer
4小时前
待确认
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration
18天前
已完结
Meningiomas
3个月前
已完结
Glioblastoma and Other Primary Brain Malignancies in Adults
3个月前
已完结
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study
3个月前
已完结
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study
3个月前
已完结
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
7个月前
已完结
Antibody-drug conjugates: in search of partners of choice
7个月前
已完结
Role of Nectin‑4 protein in cancer (Review)
7个月前
已完结
皖公网安备34019202002308
